Skip to main content
Premium Trial:

Request an Annual Quote

NHGRI to Publish Six RFAs for Genome Sequencing

NEW YORK, Dec. 12 (GenomeWeb News) - The National Human Genome Research Institute plans to issue six requests for applications for projects focusing on genome sequencing technologies, the National Institutes of Health said last week.

 

The amounts allocated for the awards will be available once the RFAs are published, NHGRI said.

 

The research scope for these RFAs will be the same as the ones issued in 2004 on near-term technology development for genome sequencing and on revolutionary genome sequencing technologies. NHGRI committed $8 million in fiscal year 2004 and $5 million in fiscal year 2005 to fund four to 10 grants for near-term technology projects. For projects on revolutionary technologies, the NHGRI committed $6 million in fiscal year 2004 and $5 million in fiscal year 2005 to fund three to 10 awards.

 

The receipt date for intents will be Jan. 17 and applications must be submitted by Feb. 17.

 

More information can be found here.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.